J&J closes Pfizer deal
This article was originally published in The Tan Sheet
Executive Summary
Johnson & Johnson announces Dec. 20 the closing of its previously announced acquisition of Pfizer Consumer Healthcare for $16.6 billion in cash. "The completion of the Pfizer Consumer Healthcare acquisition builds upon our broad base in health products and reflects our longstanding strategy of leadership within attractive health care markets," J&J Chairman and CEO William C. Johnson says. Brands included in the transaction include Listerine, Nicorette and Sudafed. The Federal Trade Commission cleared the transaction Dec. 12 (1"The Tan Sheet" Dec. 18, 2006, p. 9)...